Market Access/ News/ News FDA clears Takeda drug for post-transplant CMV infections Phil Taylor antiviral, CMV, Livtencity, maribavir, Takeda, transplant 0 Comment Takeda has scored the first-ever FDA approval of a treatment for refractory cytomegalovirus (CMV) infections in organ transplant Share X FDA clears Takeda drug for post-transplant CMV infections https://pharmaphorum.com/news/fda-clears-takeda-drug-for-post-transplant-cmv-infections/
Market Access/ News/ News FDA panel backs Takeda’s CMV drug for transplant patients Phil Taylor antiviral, CMV, fda, infectious disease, maribavir, Takeda, transplant 0 Comment Takeda is closing on a first FDA approval in the treatment of refractory cytomegalovirus (CMV) infections in organ Share X FDA panel backs Takeda’s CMV drug for transplant patients https://pharmaphorum.com/news/fda-panel-backs-takedas-cmv-drug-for-transplant-patients/
antiviral, CMV, Livtencity, maribavir, Takeda, transplant
0 Comment
